Overview

Patiromer With or Without Food for the Treatment of Hyperkalemia

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of patiromer administered once daily (QD) when given with food compared to without food (experimental treatment group) for the treatment of hyperkalemia (high potassium in the blood).
Phase:
Phase 4
Details
Lead Sponsor:
Relypsa, Inc.